Holen Sie sich die Stockscreener-App
20.06
1.31%
0.26
Handel nachbörslich:
20.32
0.26
+1.30%
Schlusskurs vom Vortag:
$19.80
Offen:
$20.25
24-Stunden-Volumen:
2.40M
Relative Volume:
0.72
Marktkapitalisierung:
$2.86B
Einnahmen:
$62.38M
Nettoeinkommen (Verlust:
$-101.59M
KGV:
-23.21
EPS:
-0.8644
Netto-Cashflow:
$-139.93M
1W Leistung:
-5.47%
1M Leistung:
+18.35%
6M Leistung:
+190.30%
1J Leistung:
+1,558%
1-Tages-Spanne:
$19.62
$20.54
1-Wochen-Bereich:
$19.24
$22.20
52-Wochen-Spanne:
$1.03
$22.20
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Compare TNGX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
20.06 | 2.83B | 62.38M | -101.59M | -139.93M | -0.8644 |
VRTX
Vertex Pharmaceuticals Inc
|
443.92 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
775.53 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
785.07 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.25 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.19 | 33.72B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-23 | Eingeleitet | Mizuho | Outperform |
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets - The Globe and Mail
Stifel and Jefferies raise targets on Tango Therapeutics (TNGX) - MSN
Symbol lookup from Yahoo Finance - Yahoo Finance Australia
Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) - Insider Monkey
Tango Therapeutics (NASDAQ:TNGX) Trading Down 4.3%Here's What Happened - marketbeat.com
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
Tango Therapeutics is the best performing healthcare stock in March - MSN
10 Best Performing Stocks of Q1 2026 to Watch for Q2 - Insider Monkey
Canaccord Genuity initiates coverage of Tango Therapeutics (TNGX) with buy recommendation - MSN
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells 27,000 Shares of Stock - MarketBeat
Tango Therapeutics stock hits all-time high at 21.84 USD By Investing.com - Investing.com Canada
Tango Therapeutics president sells $572k in shares By Investing.com - Investing.com Canada
Tango Therapeutics (NASDAQ: TNGX) president sells 27,000 shares - Stock Titan
Tango a new Buy at Canaccord Genuity on 2026 catalysts - MSN
Tango stock is a new Buy at Canaccord Genuity (TNGX:NASDAQ) - Seeking Alpha
Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month HighHere's Why - MarketBeat
TNGX Should I Buy - Intellectia AI
Tango Therapeutics stock hits all-time high at 21.84 USD - Investing.com
Canaccord Genuity Group Begins Coverage on Tango Therapeutics (NASDAQ:TNGX) - MarketBeat
CCORF Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $30 - Moomoo
Tudor Investment Corp ET AL Takes $450,000 Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
TNGX Stock Price, Quote & Chart | TANGO THERAPEUTICS INC (NASDAQ:TNGX) - ChartMill
Is Tango Therapeutics Inc a strong candidate for buy and hold2026 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Decliners Report: Can Tango Therapeutics Inc be recession proof2026 Fed Impact & Free Reliable Trade Execution Plans - baoquankhu1.vn
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
Tango Therapeutics (TNGX) price target increased by 32.09% to 20.06 - MSN
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge - AOL.com
Tango Therapeutics is the best performing healthcare stock in March (XLV:NYSEARCA) - Seeking Alpha
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum - Yahoo Finance
Geopolitics Watch: Can Tango Therapeutics Inc ride the EV waveTrade Performance Summary & Community Verified Trade Alerts - baoquankhu1.vn
Adam Crystal Sells 12,000 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
VIX Spike: Is Tango Therapeutics Inc a strong candidate for buy and holdSwing Trade & Risk Managed Investment Signals - baoquankhu1.vn
Tango Therapeutics president sells $241k in shares By Investing.com - Investing.com South Africa
Tango Therapeutics president sells $241k in shares - Investing.com
Tango Therapeutics (TNGX) R&D chief exercises options, sells 12,000 shares - stocktitan.net
Momentum Shift: Is Tango Therapeutics Inc stock good for income investors2026 Volume & Consistent Profit Alerts - baoquankhu1.vn
TNGXTango Therapeutics Inc Stock Price and Quote - Finviz
Tango Therapeutics (NASDAQ: TNGX) — Vanguard reports 0 shares after realignment - Stock Titan
B. Riley Securities Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $21 - Moomoo
B. Riley Raises Price Target on Tango Therapeutics to $21 From $14, Keeps Buy Rating - MarketScreener
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.51%
1.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):